Table 2.
Selected structurally diverse compounds and 2-HNA analogs for in vitro characterization as putative NAPRT inhibitors.
| Compound ID | Structure | Vendor ID | M.W. * | Compound ID | Structure | Vendor ID | M.W. |
|---|---|---|---|---|---|---|---|
| 1 |
|
F0020-0171 | 333.3407 | 26 |
|
F2721-0386 | 337.3709 |
| 2 |
|
F0173-0133 | 349.4063 | 27 |
|
F2758-0213 | 297.2688 |
| 3 |
|
F0648-0699 | 376.3655 | 28 |
|
F3188-0088 | 277.2759 |
| 4 |
|
F0648-0785 | 391.3769 | 29 |
|
F3226-2226 | 397.4427 |
| 5 |
|
F1199-0146 | 358.7757 | 30 |
|
F3229-0191 | 283.7076 |
| 6 |
|
F1260-1693 | 421.4889 | 31 |
|
F3295-0007 | 355.3927 |
| 7 |
|
F1299-0156 | 462.6037 | 32 |
|
F3311-0032 | 471.9565 |
| 8 |
|
F1371-0219 | 139.1088 | 33 |
|
F3371-0859 | 414.4268 |
| 9 |
|
F1566-0988 | 333.3192 | 34 |
|
F3385-4161 | 440.9226 |
| 10 |
|
F1710-0049 | 460.429 | 35 |
|
F5008-0290 | 369.3977 |
| 11 |
|
F1811-0048 | 282.2957 | 36 |
|
F5857-5354 | 311.3319 |
| 12 |
|
F1907-0958 | 230.2194 | 37 |
|
F6127-0104 | 303.2769 |
| 13 |
|
F1967s-1157 | 180.1607 | 38 |
|
F6127-0210 | 333.3574 |
| 14 |
|
F2135-0162 | 181.1455 | 39 |
|
F6241-0336 | 388.4408 |
| 15 |
|
F2135-0875 | 276.2911 | 40 |
|
F6252-1248 | 277.3206 |
| 16 |
|
F2135-0897 | 228.2466 | 41 |
|
F6252-5764 | 436.4869 |
| 17 |
|
F2147-0724 | 174.1513 | 42 |
|
F6279-0434 | 365.4008 |
| 18 |
|
F2168-0001 | 153.1354 | 43 |
|
F6372-1828 | 407.3795 |
| 19 |
|
F2169-0490 | 130.1252 | 44 |
|
F6414-0992 | 404.4584 |
| 20 |
|
F2191-0003 | 153.1354 | 45 |
|
F6439-7266 | 398.4604 |
| 21 |
|
F2278-0232 | 316.3748 | 46 |
|
F6465-0031 | 290.2747 |
| 22 |
|
F2503-0045 | 331.3497 | 47 |
|
F6497-7775 | 383.3796 |
| 23 |
|
F2526-0046 | 346.1572 | 48 |
|
F6497-8054 | 447.4104 |
| 24 |
|
F2711-0182 | 305.3042 | 49 |
|
F6523-1712 | 367.4017 |
| 25 |
|
F2721-0331 | 346.2091 | 50 |
|
F9994-0201 | 397.4078 |
* M.W: Molecular weight.